IONIS PHARMACEUTICALS INC - 8-K Filing
Ionis Pharmaceuticals appointed Ludwig N. Hantson as a member of its Board of Directors effective June 4, 2026, following the company's annual stockholder meeting where five proposals were approved by shareholders including director elections and equity plan amendments. Dr. Hantson brings over 30 years of biopharmaceutical leadership experience from companies like Alexion and Baxter Bioscience. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $IONS